Browse All

Current Filters

CLEAR FILTER x

TITLE

Reduced Clinical Deteriorations and Healthcare Resource Utilization After Switching from Efgartigimod to Ravulizumab in Patients with Generalized Myasthenia Gravis in the United States

The Uptake, Intracellular Trafficking and Recycling of FcRn-blocking Therapeutics in Human Endothelial Cells in Vitro

Designing AChR-mimicking Nanobody Decoys to Neutralize Pathogenic IgG1 Autoantibodies in Myasthenia Gravis